Zhejiang Garden Biopharmaceutical Co Ltd
300401
Company Profile
Business description
Zhejiang Garden Biopharmaceutical Co Ltd is a China-based company. Along with its subsidiaries, the firm is engaged in the pharmaceutical manufacturing. Its business activities include research, production, and sale of vitamin D3, cholesterol, and lanolin products. Its products include lanolin alcohol pharma, lanolin alcohol cosmetic, cholesterol BP, vitamin D3 oil feed grade, vitamin D3 500 feed grade CWS, lanolin alcohol EP 200, among others.
Contact
No. 166, Street 20
Economic & Technological Development Zone
Zhejiang
Hangzhou310018
CHNT: +86 57186571196
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,021
Stocks News & Analysis
stocks
Ask the analyst: Are Qantas shares a value trap?
Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?
stocks
Palantir earnings: Blockbuster growth amid high expectations
We raise our fair value estimate off the back of earnings.
stocks
ResMed earnings: Solid showing from ASX healthcare winner
Strong demand growth and improved profit margins lead to a strong result from the sleep apnea device firm.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,111.10 | 82.30 | 0.91% |
| CAC 40 | 7,635.03 | 13.99 | 0.18% |
| DAX 40 | 23,924.36 | 78.29 | 0.33% |
| Dow JONES (US) | 44,193.12 | 81.38 | 0.18% |
| FTSE 100 | 9,164.31 | 21.58 | 0.24% |
| HKSE | 24,910.63 | 8.10 | 0.03% |
| NASDAQ | 21,169.42 | 252.87 | 1.21% |
| Nikkei 225 | 40,794.86 | 245.32 | 0.60% |
| NZX 50 Index | 12,924.03 | 43.87 | 0.34% |
| S&P 500 | 6,345.06 | 45.87 | 0.73% |
| S&P/ASX 200 | 8,843.70 | 73.30 | 0.84% |
| SSE Composite Index | 3,633.99 | 16.40 | 0.45% |